https://www.selleckchem.com/products/odm-201.html
BACKGROUND Prostate cancer is the second most common cause of male cancer death after lung cancer in the US. Therefore, there is an urgent need for a highly effective therapeutic drug at substantially low doses. OBJECTIVE Anti-androgen drug flutamide was delivered to the prostate cancer cells using papain mediated synthesized gold nanoparticles (PGNPs) as the drug delivery system. PGNPs and flutamide worked synergistically against cancer cells. METHOD Flutamide was used to bioconjugate with PGNPs to improve its efficacy against prostate
Like
Comment
Share
